Akero Therapeutics Stock Predictions

Former Zillow execs target $1.3T market

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Sell

AKRO
Akero Therapeutics

Last Price:

$39.89

Seasonality Move:

15.51%

7 Day Trial

ALL ACCESS PASS

$ 7

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Akero Therapeutics Stock Forecast

Over the next 52 weeks, Akero Therapeutics has on average historically risen by 64.1% based on the past 5 years of stock performance.
Akero Therapeutics has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Is Akero Therapeutics Stock Undervalued?

The current Akero Therapeutics [AKRO] share price is $39.85. The Score for AKRO is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
AKRO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Akero Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Akero Therapeutics has on average historically risen by 64.1% based on the past 5 years of stock performance.

Akero Therapeutics Stock Rating

Sell

Akero Therapeutics (AKRO) is a Sell

Is Akero Therapeutics overpriced?

Akero Therapeutics has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Akero Therapeutics Stock Price History

Is AKRO stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

akerotx.com

52-Week Data

52-Week High:

58.40

52-Week Low:

17.86

Prediction Charts

Market Cap:

3.2B

Price in USD:

39.85

Volume:

1.3M

Beta:

-0.04

Technical Analysis

SMA50:

41.94

SMA100:

39.73

SMA200:

34.13

52-Wk Change:

91.59%

Stock Predictions

Is Akero Therapeutics stock public?

Yes, Akero Therapeutics is a publicly traded company.
What is the Akero Therapeutics stock quote today?

The Akero Therapeutics stock price is 39.85 USD today.
How to buy Akero Therapeutics stock online?

You can buy Akero Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Apr-22	38.03	38.50	39.28	38.00
Apr-23	39.66	39.61	40.59	38.86
Apr-24	39.56	40.99	41.44	39.05
Apr-25	40.53	41.00	41.61	40.33
Apr-28	41.35	42.17	42.43	41.12
Apr-29	41.89	43.04	43.45	41.34
Apr-30	42.90	45.61	45.81	42.71
May-1	45.31	45.31	45.92	43.60
May-2	45.51	44.87	46.47	44.08
May-5	44.47	44.92	45.24	43.71
May-6	44.00	42.02	44.62	41.77
May-7	42.56	42.79	43.27	41.60
May-8	42.77	42.39	44.48	41.97
May-9	42.39	39.85	44.81	39.66

Akero Therapeutics Earnings

Akero Therapeutics Earnings Report: Per Share Akero Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Akero Therapeutics Forecast Revenue Growth

Akero Therapeutics Stock Analysis: Historical quarterly revenues per share for Akero Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and a decrease next year of $0.48 per share.

* Akero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.